Viral Vaccine Manufacturing Services to Support Complex Market Demands

Vaccines

With over a decade of experience in viral vaccine manufacturing, SAFC® has leading expertise using viral technology to support industry demand from process development to cGMP manufacture of master cell banks, viral banks and clinical drug products. SAFC dedicated viral manufacturing site features:

	Eight client-dedicated Class 10,000 (ISO 7) clean room suites
	Single-pass air, exhausted directly from clean rooms
	Aseptic manipulations performed in Class 100 (ISO 5) biosafety cabinets
	Two dedicated Class 1,000 (ISO 6) fill suites
	100 L stainless steel bioreactors
	Disposable capacity up to 1,000 L
	Preclinical to Commercial bulk drug manufacturing capabilities

Learn more about our Carlsbad facility.

Increased Effectiveness Through Bio-Conjugation

With over 30 years of experience in conjugation of biological and chemical molecules, SAFC provides process development and a full analytical package to support conjugation projects and cGMP production from early stage development to commercial scale. Over 400 analytical tests are available in our St. Louis US facility, which is SafeBridge® certified for our ability to safely handle high-potent compounds and perform consistent conjugation for when applicable to vaccine products.

More information on bio-conjugation services.

cGMP Liquid Fill/Finish Services

SAFC provides Fill/Finish services for biologic drug products as well as small molecule APIs. These services are provided in a state-of-the-art facility with two Class 100 filling suites (ISO 5). SAFC's liquid fill/ finish capabilities and expertise in filling viral vaccines provides our customers with consistent high-quality fills. Using semi and fully-automated fill lines, SAFC specialists demonstrate exceptional care in custom fills with an enviable service record over 300 lots.

More information on fill/finish services.

Back to Vaccines home